M&A / Deals Sun sets out $11.75bn takeover play for Organon PharmaphorumAfter downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon.Read full story pharminent April 27, 2026 (Last updated: April 27, 2026) Pharmaphorum After downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Gene therapy leaders aim to help more Baby KJs with novel regulatory modelsNext: Sun Pharma to acquire Organon for $11.75bn Related Stories M&A / Deals Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar pharminent July 10, 2026 M&A / Deals GSK ends dementia alliance with Alector after setbacks pharminent July 9, 2026 M&A / Deals AstraZeneca, GSK intensify China ties with Sino Biopharm deals pharminent July 8, 2026
